FR2837105A1 - Synergistic medicinal combination of propolis and lavender essential oil, e.g. as extract obtained by maceration, useful e.g. for treating infections, inflammation, wounds, pain or hemorrhoids - Google Patents

Synergistic medicinal combination of propolis and lavender essential oil, e.g. as extract obtained by maceration, useful e.g. for treating infections, inflammation, wounds, pain or hemorrhoids Download PDF

Info

Publication number
FR2837105A1
FR2837105A1 FR0203093A FR0203093A FR2837105A1 FR 2837105 A1 FR2837105 A1 FR 2837105A1 FR 0203093 A FR0203093 A FR 0203093A FR 0203093 A FR0203093 A FR 0203093A FR 2837105 A1 FR2837105 A1 FR 2837105A1
Authority
FR
France
Prior art keywords
propolis
essential oil
lavender
extract
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0203093A
Other languages
French (fr)
Other versions
FR2837105B1 (en
Inventor
Jean Bringer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0203093A priority Critical patent/FR2837105B1/en
Publication of FR2837105A1 publication Critical patent/FR2837105A1/en
Application granted granted Critical
Publication of FR2837105B1 publication Critical patent/FR2837105B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Abstract

A natural product-based composition (I), for use in the production of medicinal extracts, comprises an alcohol-free combination of propolis and lavender essential oil. Independent claims are included for: (1) an alcohol-free liquid extract (II), obtained from (I) (preferably by maceration); (2) the preparation of (I), by introducing 5-20 (especially 12) parts propolis (previously ground to fine powder at 10-15 degrees C) into a container, adding lavender oil to a total of 100 parts and manually mixing; and (3) the preparation of (II) by forming (I) as in (2) then allowing the mixture to macerate for 1-4 (especially 2.5) months, filtering the liquid phase and recovering and storing the filtrate.

Description

NH2.NH2.

COMPOSITION ASSOCIANT LA PROPOLISCOMPOSITION COMBINING PROPOLIS

i 5 A UNE ESSENCE AROMATIQUE La presente invention conceme des praduits d'origine naturelle, en particulier des produits de la ruche et des essences aromatiques, possedant des proprietes utiles dans le domaine des l 0 therapeutiques naturelles , La presente invention a pour objet une composition destinee a la preparation d'un extrait i liquide ayant un usage medical, comprenant en association au moins la propolis et une huile essentielle de lavande, et ne contenant pas d'alcool. L'extrait obtenu a partir de ladite lS composition et les procedes de preparation de ladite composition et audit extrait vent  i 5 HAS AN AROMATIC ESSENCE The present invention relates to praducts of natural origin, in particular beehive products and aromatic essences, having properties useful in the field of natural therapeutics, The subject of the present invention is a composition intended for the preparation of a liquid extract having a medical use, comprising in association at least propolis and an essential oil of lavender, and not containing alcohol. The extract obtained from said composition and the processes for preparing said composition and said wind extract

egalernent des objets de ['invention.  also objects of the invention.

La lavande est une plante aromatique de la famille des labiees (ou lamiacees) du genre Lavandula. On connait en particulier l'espece Lavandula oicinalis, ainsi que son hybride largement utilise pour la production d' essence, le lavandin. L 'huile essentielle de lavande (ou  Lavender is an aromatic plant of the labiae (or lamiaceous) family of the genus Lavandula. We know in particular the species Lavandula oicinalis, as well as its hybrid widely used for the production of essence, lavandin. Lavender essential oil (or

de lavandin) est ['essence pure obtenue par distillation de la lavande ou de son hybride.  of lavandin) is the pure essence obtained by distillation of lavender or its hybrid.

La lavande et le lavandin ont ete tres utilises dans l'ancienne pharmacopee sous formes diverges: tisanes, cataplasmes, onguents, compresses, potions.... Ils vent utilises de nos jours sous la forme concentree d'huile essentielle, en tent que principe actif dans des preparations medicamenteuses destinees au traitement de divers troubles, par exemple les affections bronchiques, le nettoyage de la peau et des muqueuses, ou encore ['elimination  Lavender and lavandin were very used in the old pharmacopoeia in different forms: herbal teas, poultices, ointments, compresses, potions .... They are used nowadays in the concentrated form of essential oil, trying as a principle active in medicinal preparations intended for the treatment of various disorders, for example bronchial affections, cleaning of the skin and mucous membranes, or even 'elimination

renale de l'eau.water renal.

j 30 La propolis est une substance naturelle, recueillie par les abeilles sur certaines parties des vegetaux, essentiellement les bourgeons et l'ecorce de certains coniferes, tels que le pin et le sapin, et des feuillus, essentiellement le peuplier, mais aussi le chene, l'aulne, le saule, le - bouleau ou le frene. Dans la ruche, elle est modifiee par les abeilles qui y ajoutent leurs | propres secretions, comme de la cire et des secretions salivaires. Wile a une consistence p 35 visqueuse plus ou moins malleable en fonction de la temperature ambiante, qui la fait comparer a un ciment ou un vernis. Wile est utilisee par les abeilles pour colmater les fentes et les fissures de la ruche, en consolider la structure, reparer les rayons, vernisser les surfaces i . ! 2 interieures afin d' en supprimer l es asp erites. On considere que ces fonctions  j 30 Propolis is a natural substance, collected by bees from certain parts of plants, mainly the buds and bark of certain conifers, such as pine and fir, and deciduous trees, mainly poplar, but also oak. , alder, willow, birch or ash. In the hive, it is modified by the bees who add their | own secretions, such as wax and saliva secretions. Wile has a viscous consistency p 35 more or less malleable depending on the ambient temperature, which makes it compare to a cement or a varnish. Wile is used by bees to seal cracks and cracks in the hive, consolidate the structure, repair the combs, varnish the surfaces i. ! 2 interiors to remove the rough edges. These functions are considered

s'accompagnent d'un effet desinfectant dans la ruche.  are accompanied by a disinfectant effect in the hive.

La propolis peut etre recueillie au niveau de la ruche par differentes techniques. Par exemple, on peut proceder par grattage des cadres ou des parois de la ruche, de preference par temperature inferieure a 15 C, la propolis etant alors cure et friable et se detachant plus facilement. Certains auteurs recommandent de pratiquer la recolte au cours de l'ete, apres la miellee principale. La quantite recoltee est variable, en general 100 a 200 grammes par ruche  Propolis can be collected from the hive by different techniques. For example, it is possible to scrape the frames or the walls of the hive, preferably at a temperature below 15 C, the propolis then being cured and brittle and coming off more easily. Some authors recommend harvesting during the summer, after the main honey. The quantity harvested is variable, generally 100 to 200 grams per hive

et par an. La propolis est alors debarrassee de ses impuretes par filtration a chaud.  and per year. The propolis is then rid of its impurities by hot filtration.

Wile se presente a temperature ambiante sous ['aspect d'une masse solide de couleur  Wile occurs at room temperature as a solid colored mass

generalement brune plus ou moins foncee, et pouvant aller du jaune au brun tres fonce.  generally brown more or less dark, and can range from yellow to very dark brown.

Refroidie a 15 C, la propolis devient cure et cassante, tandis qutelle devient moue et  Cooled to 15 C, the propolis becomes cured and brittle, while it becomes pouty and

malleable a l'approche des 30 C. Son point de fusion se situe autour de 60-70 C.  malleable when approaching 30 C. Its melting point is around 60-70 C.

Wile est insoluble dans l'eau a froid et partiellement soluble a la temperature d'ebullition.  Wile is insoluble in cold water and partially soluble at boiling temperature.

L'emploi de solvents orgaTques permet une dissolution partielle de la propolis. Cependant, ! senl un melange adequat de differents solvents permet de dissoudre la quasi-totalite de ses composants. La propolis est connue de longue date pour ses effets benefiques sur la sante. Wile est dotee de proprietes antibiotiques agiss ant sur de nombreuses souches microbi ennes, auxquell es il faut ajouter des proprietes anesthesiques, cicatrisantes et anti-inflammatoires. Wiles est preconisee pour renforcer la resistance naturelle de l'organisme dans sa lutte contre les 1 25 agressions chez la personne seine comme chez la personne malade. Wile est particulierement recommandee pour le traitement des affections de la sphere ORL, les troubles digestifs et contre les infections et inflmnmations en general ("La propolis", Dr Y. DONADIEU,  The use of organic solvents allows partial dissolution of propolis. However,! senl an adequate mixture of different solvents allows to dissolve almost all of its components. Propolis has been known for a long time for its beneficial effects on health. Wile has antibiotic properties that act on many microbial strains, to which must be added anesthetic, healing and anti-inflammatory properties. Wiles is recommended to reinforce the natural resistance of the organism in its fight against 1 25 aggressions in the healthy person as in the sick person. Wile is particularly recommended for the treatment of affections of the ENT sphere, digestive disorders and against infections and inflammation in general ("Propolis", Dr Y. DONADIEU,

Maloine Ed., 1986).Maloine Ed., 1986).

, 30 Cette substance complexe contient en effet de nombreux constituents qui ont ete identifies | par les techniques d'analyse modernes. En particulier, les analyses chimiques ont permis de mettre en evidence la presence de composants appartenant a des group es chimiques connus i pour leurs proprietes therapeutiques, tels que des acides organiques (acide benzoique, acide gallique), des acides-phenols (acide cafeique, acide cinnamique, acide ferulique, acide isoferulique, acide p-coumarique), des aldebydes aromatiques (la vanilline, l'isovanilline), des coumarines (l'esculetol, le scopoletol), ou encore des flavonoides tels que des flavones, et ses derives alcooliques, cetoniques et cetoliques (flavonols, flavones et flavononols). Wile contient i }, .  , 30 This complex substance indeed contains many constituents which have been identified | by modern analytical techniques. In particular, chemical analyzes have made it possible to highlight the presence of components belonging to chemical groups known i for their therapeutic properties, such as organic acids (benzoic acid, gallic acid), acid-phenols (caffeic acid, cinnamic acid, ferulic acid, isoferulic acid, p-coumaric acid), aromatic aldebyds (vanillin, isovanillin), coumarins (esculetol, scopoletol), or flavonoids such as flavones, and its derivatives alcoholic, cetonic and cetolic (flavonols, flavones and flavononols). Wile contains i},.

28371 0528371 05

egalement des precurseurs des vitmines telle que la provitamine A et certaines vitarnines telles que la vitamine B3 et PP. La composition detaillee de la propolis est decrite dans la litteratue, par exernple dans ['article de Van?naelen M. et Vanhaelen-Fastre R. 1980,  also precursors of vitamins such as provitamin A and certain vitarnines such as vitamin B3 and PP. The detailed composition of propolis is described in the literature, for example in the article by Van? Naelen M. and Vanhaelen-Fastre R. 1980,

Belgique Apicole, septembre et octobre).  Beekeeping Belgium, September and October).

Jusquta present, elle a ete utilisee soit telle queue a l'etat nature!, soit sous forme d'extrait alcoolique. On la trouve dans le commerce sous forme de pate a macher, de granules, ou de poudre. Wiles est alors ingeree apres mastication ou avalee directement, de sorte que les substances actives de la propolis se trouvent confrontes aux sues gastriques avant d'etre assimilees par l'organisme. De ce fait, certaines substances actives vent degradees ou denaturees avant  Until now, it has been used either in its natural state, or in the form of an alcoholic extract. It is found commercially in the form of chewing dough, granules, or powder. Wiles is then ingested after chewing or swallowed directly, so that the active substances in propolis are confronted with gastric sweat before being assimilated by the body. As a result, certain active substances are degraded or denatured before

d'atteindre leur cible.reach their target.

Wile peut egalement etre employee sous forme d'extrait. On connait la teinture alcoolique de propolis obtenue par maceration, dissolution ou lixivation dans une solution d' ethanol. Cette teinture peut etre evaporee pour obtenir un extrait sec. Cependant, comme indique plus haut, la solubilite de la propolis est relativement faible et seuls certains de ses composants vent solubles dans les solvents organiques usuels. Or, le solvent joue un role essentiel dans la nature des composants extraits de la fraction solide. On perd ainsi une partie importante des substances actives, et l'effet attendu en est amoindri dans son ampleur et modifie dans sa nature. I1 apparait done essential, pour obtenir un extrait plus concentre et de champ d'action elargi, de disposer d'un solvent capable d'extraire plus efficacement les principes actifs. De maniere surprenante, il a ete trouve que ['association de la propolis avec une essence de lavande repond a cet objectiú I1 a ete constate en outre qu'en presence d'essence de lavande, I'effet de la propolis est superieur a celui attendu par le simple jeu de la concentration de ltextrait. En effet, on a pu constater que lthuile essentielle de lavande agit non senlement en tent que principe actif completant l'effet de la propolis, mais aussi en renforce ['action. On peut supposer que cette amplification est due a la combinaison des proprietes de solvent de l'huile de lavande vis- a-vis des substances actives de la propol is, avec s es proprietes liposolub les qui j favorisent la penetration des principes actifs a travers la peau et les muqueuses. Les actifs arrivent ainsi rapidernent via le flux sanguin dans les tissue et les differents organes. Ainsi, la combinaison de l'huile essentielle de lavande avec la propolis, confere un pouvoir d' action  Wile can also be used as an extract. We know the alcoholic tincture of propolis obtained by maceration, dissolution or leaching in an ethanol solution. This tincture can be evaporated to obtain a dry extract. However, as indicated above, the solubility of propolis is relatively low and only some of its components are soluble in the usual organic solvents. However, the solvent plays an essential role in the nature of the components extracted from the solid fraction. A significant part of the active substances is thus lost, and the expected effect is lessened in its magnitude and changes in its nature. It therefore appears essential, in order to obtain a more concentrated extract with a wider field of action, to have a solvent capable of extracting the active ingredients more effectively. Surprisingly, it has been found that the association of propolis with a lavender essence meets this object. It has also been found that in the presence of lavender essence, the effect of propolis is greater than that expected by the simple game of concentration of the text. In fact, it has been observed that the essential oil of lavender acts not only as an active ingredient complementing the effect of propolis, but also strengthening its action. We can suppose that this amplification is due to the combination of the solvent properties of lavender oil vis-à-vis the active substances of propol is, with its liposolub properties which favor the penetration of the active ingredients through the skin and mucous membranes. The active ingredients thus arrive quickly via the blood flow in the tissues and the various organs. Thus, the combination of lavender essential oil with propolis, gives a power of action

| 28371 05| 28371 05

! 4 plus rapide et plus intense a l'extrait liquide prepare a partir de la composition selon ['invention. La presente invention a ainsi pour premier objet une composition a base de produits - 5 d'origine naturelle destinee a la preparation d'un extrait a usage medical, comprenant en association au moins la propolis et une huile essentielle de lavande, et ne contenant pas d'alcool. La propolis est obtenue comme indiqud precedemment par raclage des cadres de la ruche, de preference en ete, a une temperature de 10 C a 15 C. Wile est introduite dans la composition selon ['invention sous forme d'une poudre fnement broyee, en general a ['aide d'un broyeur mecanique, par exemple un moulin a cafe. Wile represente de 5 % a 20 % en poids de la composition totale. De preference, la composition selon ['invention comprend 12% de  ! 4 faster and more intense with the liquid extract prepared from the composition according to the invention. The present invention thus has for first object a composition based on products - 5 of natural origin intended for the preparation of an extract for medical use, comprising in combination at least propolis and an essential oil of lavender, and not containing alcohol. Propolis is obtained as indicated above by scraping the frames of the hive, preferably in summer, at a temperature of 10 ° C. to 15 ° C. Wile is introduced into the composition according to the invention in the form of a finely ground powder, in general using a mechanical grinder, for example a coffee grinder. Wile represents from 5% to 20% by weight of the total composition. Preferably, the composition according to the invention comprises 12% of

propolis en poids.propolis by weight.

Dans la composition selon ['invention, on utilise une huile essentielle aromatique, avantageusement une huile essentielle de lavande. Dans la presente demande, on entend par lavande, tout vegetal du genre Lavandula, en particulier Lavandula officinalis, ainsi que ses hybrides utilises pour la production d' essence, tel que le lavandin. L 'huile essentielle de lavande pure est obtenue par distillation. Wile est disponible dans le commerce ou aupres des fournisseurs de l'industrie des parfums et aromes. La quantite utile peut aller de 80 % a 95  In the composition according to the invention, an aromatic essential oil is used, advantageously an essential oil of lavender. In the present application, the term “lavender” means any plant of the genus Lavandula, in particular Lavandula officinalis, as well as its hybrids used for the production of gasoline, such as lavandin. Pure lavender essential oil is obtained by distillation. Wile is available commercially or from suppliers in the perfume and aroma industry. The useful quantity can range from 80% to 95

% d'huile essentielle de lavande, et de preference 88 %, en poids de composition totale.  % lavender essential oil, and preferably 88%, by weight of total composition.

De maniere avantageuse, la composition selon la presente invention est composee de 12 % de  Advantageously, the composition according to the present invention is composed of 12% of

propolis et 88 % d'huile essentielle de lavande, en poids. Wile ne contient pas d'alcool.  propolis and 88% lavender essential oil, by weight. Wile does not contain alcohol.

L'extrait liquide susceptible d'etre obtenu a pardr de la composition selon ['invention est egalement un objet de la presente invention. De preference, cet extrait est obtenu par maceration de ladite composition, ctest-a-dire par extraction a temperature ambiante. Aucun  The liquid extract capable of being obtained from the composition according to the invention is also an object of the present invention. Preferably, this extract is obtained by maceration of said composition, that is to say by extraction at room temperature. No

compose alcoolique ntest utilise pour cette extraction.  alcoholic compound used for this extraction.

On met ici a profit les proprietes de solvent de lthuile essentielle de lavande qui est capable de dissoudre de nombreuses molecules organiques contenues dans la propolis. L'extrait liquide selon la presente invention est done original par le profil des fractions organiques presentes qui ont ete solubilisees par l'huile essentielle de lavande. Un autre objet de la presente invention est done un extrait liquide non alcoolise contenant les composants actifs  Here we take advantage of the solvent properties of lavender essential oil which is capable of dissolving many organic molecules contained in propolis. The liquid extract according to the present invention is therefore original by the profile of the organic fractions present which have been solubilized by the essential oil of lavender. Another object of the present invention is therefore a non-alcoholic liquid extract containing the active components

de la propolis solubles dans l'huile essentielle de lavande.  propolis soluble in lavender essential oil.

Un procede de preparation d'une composition selon ['invention est un autre objet de la presente invention. Ce procede, permettant d'obtenir une composition liquide non alcoolique, comprend au moins les etapes consistent a: - introduire dans un recipient 5 a 20 parties, de preference 12 parties, de propolis prealablement reduite en poudre fine a ['aide d'un broyeur a une temperature comprise entre C et 15 C, - completer a 100 avec de 1'huiIe essentielle de lavande, et - melanger manuellement; Le broyeur utilise peut etre n'importe quel un broyeur mecanique permettant d'obtenir une - poudre fine. Un moulin a cafe est adapte a cette operation. On se tiendra de preference dans  Another object of the present invention is a process for preparing a composition according to the invention. This process, making it possible to obtain a non-alcoholic liquid composition, comprises at least the steps consisting in: - introducing into a container 5 to 20 parts, preferably 12 parts, of propolis previously reduced to a fine powder using a grinder at a temperature between C and 15 C, - complete to 100 with essential lavender today, and - mix manually; The grinder used can be any mechanical grinder for obtaining a fine powder. A coffee grinder is suitable for this operation. We will preferably be in

un piece fiaiche, de maniere que la propolis reste cure et cassante durant le broyage.  a perfect piece, so that the propolis stays cured and brittle during grinding.

Idealement une temperature de 10 C a 15 C est recommandee, qui peut cependant etre  Ideally a temperature of 10 C to 15 C is recommended, which can however be

inferieure sans inconvenient particulier.  lower without any particular drawback.

A partir de la composition ainsi obtenue, on prepare un extrait liquide non alcoolique tel que decrit precedemment, selon un procede egalement objet de la presente invention. Ce procede comprend au moins les etapes consistent a: - preparer une composition liquide non alcoolique a base de propolis et d'huile ess entielle de lavande, par exemple par le pro cede decrit ci-dessus; - laisser macerer ladite composition pendant 1 a 4 mods, de preference 2,5 mods;  From the composition thus obtained, a non-alcoholic liquid extract as described above is prepared, according to a process also subject of the present invention. This process comprises at least the steps consisting in: - preparing a non-alcoholic liquid composition based on propolis and whole lavender essential oil, for example by the process described above; - let macerate said composition for 1 to 4 mods, preferably 2.5 mods;

- filtrer la phase liquide, recueillir ltextrait et conditionner.  - filter the liquid phase, collect the text and condition.

Le recipient dans lequel a lieu la maceration est place dans un local sans contrainte de À' temperature ou d'eclairage. n est cependant recommande d'utiliser un local tetnpere a 25 C maximum et a l'abri de la lumiere directe du soleil. Quand la maceration est tenninee, la phase liquide est filtree sur un filtre en papier, de type filtre a cafe, ou sur une etoffe fine. Le  The container in which the maceration takes place is placed in a room without temperature or lighting constraints. It is however recommended to use a local room at 25 C maximum and out of direct sunlight. When the maceration is finished, the liquid phase is filtered on a paper filter, of the coffee filter type, or on a fine cloth. The

filtrat obtenu est l'extrait selon ['invention.  The filtrate obtained is the extract according to the invention.

) 30 L'exait ainsi obtenu peut etre conserve plusieurs mods, voire plusieurs annees, a temperature  ) 30 The extract thus obtained can be kept for several mods, even several years, at temperature

j ambiante dans un recipient bouche, sans qu'aucune perte d'activite ne soit constatee.  at room temperature in a sealed container, without any loss of activity being observed.

lit La presente invention permet ainsi d'apporter une reponse aux inconvenients ou aux limites : 35 des produits commercialises a ce jour, grace a une composition associant une huile essentielle dont les effets se conjuguent a ceux de la propolis, en particulier du fait qu'elle permet une extraction poussee des composants actifs de la propolis et une penetration rapide J t r o iri f dans l'organisme par application directe sur les muqueuses ou sur la pea4 et sans destruction des substances actives au cours de la digestion. En outre ['absence de toute trace  The present invention thus makes it possible to provide a response to the drawbacks or to the limits: of the products marketed to date, thanks to a composition associating an essential oil whose effects combine with those of propolis, in particular because it allows a thorough extraction of the active components of propolis and rapid penetration into the body by direct application to the mucous membranes or pea4 and without destruction of the active substances during digestion. In addition ['absence of any trace

d'alcool rend son emploi possible a tout age.  of alcohol makes it possible to use it at any age.

Son mode d'administration de predilection se deduit de ce qui precede: la voix cutanee (peau ou muqueuse) sera privilegiee. On pourra par exemple realiser une application par vole  Its preferred mode of administration is deduced from the above: the cutaneous voice (skin or mucous membrane) will be privileged. We could for example realize an application by flight

externe, pour une action locale, par exemple cicatrisante, anesthesiante, fongicide.  external, for a local action, for example healing, anesthetic, fungicide.

Selon un mode d' administration interne, on choisira la vole sublinguale. On placera sous la langue un support neutre impregne de quelques gouttes de ltextrait selon 1'invention, pendant quelques minutes a une demi-heure. Le support pourra etre aussi bien un comprime  According to an internal mode of administration, one will choose the sublingual flight. A neutral support impregnated with a few drops of the extract according to the invention will be placed under the tongue, for a few minutes to half an hour. The support could be a tablet as well

neutre vendu dans les pharmacies, qutun morceau de pain sec.  neutral sold in pharmacies, only a piece of dry bread.

Ses proprietes particulieres et originales font de la composition et de l'extrait en decoulant, objets de la presente invention, des produits indiques pour la preparation de specialites therapeutiques. La composition selon ['invention en effet, peut etre utilisee pour la preparation d'un produit employe dans le cadre de therapeutiques naturelles denuees de toxicite, ou de cures preventives, pour renforcer la resistance du terrain biologique face aux agressions en general. Un tel produit peut egalement etre employe dans le traitement de diverges affections et de nombreux troubles pathologiques, aigus ou chroniques,  Its particular and original properties make the resulting composition and extract, objects of the present invention, suitable products for the preparation of therapeutic specialties. The composition according to the invention, in fact, can be used for the preparation of a product used in the context of natural therapies with low toxicity, or of preventive cures, to reinforce the resistance of the biological soil against aggressions in general. Such a product can also be used in the treatment of various ailments and many pathological disorders, acute or chronic,

frequemment rencontres chez l'humain quel que soit son age.  Frequently encountered in humans regardless of age.

En particulier, la composition et ltextrait selon ['invention pourront avantageusement etre utilises pour la preparation de medicaments destines au traitement de troubles tels que par exemple, les etats infectieux, les inflammations, les lesions cutanees, les douleurs, ou les hemorroldes. Les exemples suivants permettront d'illustrer differents aspects de la mise en aeuvre de la  In particular, the composition and the text according to the invention can advantageously be used for the preparation of medicaments intended for the treatment of disorders such as, for example, infectious states, inflammations, skin lesions, pain, or hemorrhoids. The following examples will illustrate different aspects of the implementation of the

presente invention.present invention.

1' 3o 1,1 '3o 1,

EXEMPLESEXAMPLES

1.1.

Exemple 1Example 1

Preparation d'unextraitpropolis-lavandin À1' i Une composition a base de propolis et d' essence de lavandin a d' abord ete preparee. Pour . .. 2j' ! cela, 6 grammes de propolis prealablement reduite en poudre fine a ['aide d'un moulin a cafe menager ont ete introduits dans un recipient. Cette operation s'est deroulee dans un piece i rafraichie a 13aC, de maniere que la propolis reste cure et cassante. Puis, 44 grammes d'huile | essentielle de lavandin ont ete ajoutes, et le tout a ete melange manuellement. On obtient la  Preparation of a propolis-lavandin extract À1 'i A composition based on propolis and essence of lavandin was first prepared. For . .. 2d! this, 6 grams of propolis previously reduced to a fine powder using a household coffee grinder were introduced into a container. This operation took place in a room cooled to 13aC, so that the propolis remains cured and brittle. Then 44 grams of oil | essential lavender was added, and everything was mixed manually. We get the

composition C1.composition C1.

A partir de la composition C1 ainsi obtenue, un extrait liquide a ete prepare. Le recipient contenant la composition C1 a ete ferme et place dans un local a temperature ambiante pour la duree de la maceration. Durant les premieres deux semaines, le recipient a ete agite pendant  From the composition C1 thus obtained, a liquid extract was prepared. The container containing composition C1 was closed and placed in a room at room temperature for the duration of the maceration. During the first two weeks, the container was shaken for

une minute chaque jour.one minute each day.

- Apres 75 jours de maceration, le contenu du recipient a ete filtre sur un cone de papier (filtre a cafe). Environ 47 grammes de phase liquide ont ete recueillis. Il stagit de l'extrait propolis lavandin E1. Il a alors ete transvase dans un flacon bouche et conserve a temperature ambiante.  - After 75 days of maceration, the contents of the container were filtered on a paper cone (coffee filter). About 47 grams of liquid phase were collected. He was trained in lavender E1 propolis extract. It was then transferred to a mouth bottle and stored at room temperature.

Exemple 2Example 2

Mode d' administration interne et posologie À Adulte Senle la prescription sublinguale est conseillee. La prise se fait apres le repast Pour un adulte, deux gouttes de l'extrait E1, prepare comme dans l'exemple 1, vent deposees sur le support , neutre choisi. Le support est place sous la langue jusqu'a delitement. On repete cette prise  Method of internal administration and dosage In Adult Senle sublingual prescription is recommended. The catch is made after the repast For an adult, two drops of the extract E1, prepared as in Example 1, wind deposited on the support, neutral chosen. The support is placed under the tongue until delimited. We repeat this take

jusqu'a un maximum de 6 gouttes par 24 heures jusqu'a disparition des symptomes.  up to a maximum of 6 drops per 24 hours until the symptoms disappear.

. À Enfant Seule la prescription sublinguale est conseillee. La prise se fait apres le repast Pour un enfant de moins de 12 ens, une goutte de 1'extrait E1 prepare comme dans l'exemple 1 est deposee : 30 sur le support neutre choisi. Le support est place sous la langue jusqu'a delitement. On repete cette prise jusqu'a un maximum de 3 gouttes par 24 heures, jusquta disparition des  . For Children Only sublingual prescription is advised. The catch is made after the repast. For a child under 12, a drop of the extract E1 prepared as in Example 1 is placed: 30 on the neutral support chosen. The support is placed under the tongue until delimited. This is repeated until a maximum of 3 drops per 24 hours, until the disappearance of

- i symptomes.- i symptoms.

--

À 35 Exemple 3To 35 Example 3

Mode d' administration externe et posologie ! | Une application directe d'un extrait selon ['invention, par exemple ltextrait E1 obtenu dans I'exemple 1, est effectuee sur la zone a traiter. On deposera une a six gouttes d'extrait E1 sur i la lesion selon l'etendue a traiter et on laissera agir jusqu'a penetration totale (10 a 15 minutes). On repetera cette operation 2 a 4 fois par jour jusquta resorption complete de la lesion.  Method of external administration and dosage! | A direct application of an extract according to the invention, for example the extract E1 obtained in example 1, is carried out on the area to be treated. One to six drops of extract E1 will be placed on the lesion depending on the extent to be treated and left to act until total penetration (10 to 15 minutes). This operation will be repeated 2 to 4 times a day until complete absorption of the lesion.

n est recommande de ne pas appliquer sur les yeux ou dans les oreilles.  It is recommended not to apply on the eyes or in the ears.

Exemple 4Example 4

Tests d'activite par prise sublinguale Des essais ont ete realises, consistent en un traitement par prise sublinguale, lors de I'apparition de symptomes maladifs. Des resultats positifs ont ete obtenus dans les pathologies suivantes: - grippe: virus neutralise en moins de 8 heures; fievre: reduction rapide de l'etat fievreux; - hemorroides internee: arret de ['inflammation, puis cicatrisation; - maux de fete, migraines, mal de dos et de reins: attenuation puis disparition des douleurs,  Tests of activity by taking sublingual Tests were carried out, consist of a treatment by taking sublingual, at the appearance of sickly symptoms. Positive results have been obtained in the following pathologies: - influenza: virus neutralized in less than 8 hours; fever: rapid reduction of the feverish state; - internal hemorrhoids: stop inflammation, then scarring; - party aches, migraines, back and kidney pain: attenuation then disappearance of pain,

- rhumatismes; attenuation des douleurs.  - rheumatism; pain relief.

Exemple 5Example 5

Tests d'activite par application locale Des essais ont ete realises, consistent en un traitement par application locale, lors de lesions ou d'affections cutanees. Des resultats positifs ont ete obtenus dans les cas suivants: - coupures et blessures superficielles: desinfection et cicatrisation; - brDlures au premier degre: desinfection et cicatrisation;  Activity tests by local application Tests have been carried out, consist of a treatment by local application, during lesions or skin conditions. Positive results have been obtained in the following cases: - superficial cuts and wounds: disinfection and scarring; - first degree burns: disinfection and scarring;

- suppurations diverges: desinfection et cicatrisation rapide des plates.  - divergent suppurations: disinfection and rapid healing of the plates.

- i. v, , l i- i. v,, l i

Claims (6)

REVENDICATIONS i 5 1 - Composition a base de produits d'origine naturelle, destinee a la preparation d'un extrait a usage medical, caracterisee en ce qu'elle associe au moins la propolis et une huile essentielle de lavande, et qu'elle ne contient pas d'alcool. : :: 2 - Composition selon la revendication 1, caracterisee en ce qu'elle comprend 5 % a % de propolis et de preference 12 %, en poids.CLAIMS i 5 1 - Composition based on products of natural origin, intended for the preparation of an extract for medical use, characterized in that it combines at least propolis and an essential oil of lavender, and that it does not contains no alcohol. : :: 2 - Composition according to claim 1, characterized in that it comprises 5% to% of propolis and preferably 12%, by weight. 3 - Composition selon l'une des revendications 1 ou 2, caracterise'e en ce qutelle  3 - Composition according to one of claims 1 or 2, characterized in that comprend 80 % a 95 % d'huile essentielle de lavande, de preference 88 %, en poids.  includes 80% to 95% lavender essential oil, preferably 88%, by weight. 4 - Composition selon l'une des revendications 1 a 3, caracterisee en ce qu'elle  4 - Composition according to one of claims 1 to 3, characterized in that it comprend 12 % de propolis et 88 % d'huile essentielle de lavande, en poids.  includes 12% propolis and 88% lavender essential oil, by weight. - Extrait liquide non alcoolise susceptible d'etre obtenu a partir de la composition  - Non-alcoholic liquid extract capable of being obtained from the composition selon l'une des revendications 1 a 4, de preference par maceration.  according to one of claims 1 to 4, preferably by maceration. 6 - Extrait liquide selon la revendication 5, caracterise en ce qutil contient les  6 - Liquid extract according to claim 5, characterized in that it contains the composants actifs de la propolis solubles dans l'huile essentielle de lavande.  active components of propolis soluble in lavender essential oil. 7 - Procede de preparation d'une composition selon l'une des revendications 1 a 4  7 - Method for preparing a composition according to one of claims 1 to 4 : comprenant au moins les etapes consistent a: - introduire dans un recipient 5 a 20 parties, de preference 12 parties, de propolis prealablement reduite en poudre fine a ['aide d'un broyeur a une temperature comprise entre C et 15 C, - completer a 100 avec de l'huile essentielle de lavande, et - melanger manuellement;  : comprising at least the steps consist of: - introducing into a container 5 to 20 parts, preferably 12 parts, of propolis previously reduced to fine powder using a grinder at a temperature between C and 15 C, - make up to 100 with lavender essential oil, and - mix manually; 8 - Procede de preparation d'un extrait liquide selon l'une des revendications 5 ou 6,  8 - Method for preparing a liquid extract according to one of claims 5 or 6, | comprenant au moins les etapes consistent a: - introduire dans un recipient 5 a 20 parties, de preference 12 parties, de propolis prealablement reduite en poudre fine a ['aide d'un broyeur a une temperature comprise entre C et 15 C, completer a 100 avec de l'huile de lavande etmelanger manuellement; - laisser macerer le melange pendant l a 4 mods, de preference 2,5 mods;  | comprising at least the stages consist of: - introducing into a container 5 to 20 parts, preferably 12 parts, of propolis previously reduced to fine powder using a grinder at a temperature between C and 15 C, complete with 100 with lavender oil and mix manually; - leave the mixture to macerate for 1 to 4 mods, preferably 2.5 mods; - filtrer la phase liquide, recueillir le filtrat extrait et conditionner.  - filter the liquid phase, collect the extracted filtrate and condition. 9 - Extrait liquide obtenu par le precede selon la revendication 8.  9 - Liquid extract obtained by the process according to claim 8. - Application de la composition selon l'une des revendications 1 a 4 ou de  - Application of the composition according to one of claims 1 to 4 or l'extrait scion l'une des revendications 5 et 6 a la preparation d'un medicament destine au  extract according to one of claims 5 and 6 for the preparation of a medicament intended for traitement d'un des troubles suivants: etats infectieux, inflammations, lesions cutanees,  treatment of one of the following disorders: infectious states, inflammations, skin lesions, douleurs, hemorrodes.pain, hemorrodes.
FR0203093A 2002-03-13 2002-03-13 COMPOSITION COMBINING PROPOLIS WITH AN AROMATIC ESSENCE Expired - Fee Related FR2837105B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0203093A FR2837105B1 (en) 2002-03-13 2002-03-13 COMPOSITION COMBINING PROPOLIS WITH AN AROMATIC ESSENCE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203093A FR2837105B1 (en) 2002-03-13 2002-03-13 COMPOSITION COMBINING PROPOLIS WITH AN AROMATIC ESSENCE

Publications (2)

Publication Number Publication Date
FR2837105A1 true FR2837105A1 (en) 2003-09-19
FR2837105B1 FR2837105B1 (en) 2004-07-23

Family

ID=27772068

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0203093A Expired - Fee Related FR2837105B1 (en) 2002-03-13 2002-03-13 COMPOSITION COMBINING PROPOLIS WITH AN AROMATIC ESSENCE

Country Status (1)

Country Link
FR (1) FR2837105B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915390A1 (en) * 2007-04-24 2008-10-31 Ballot Flurin Apiculteurs Sarl PROCESS FOR TREATING PROPOLIS
ITMI20081353A1 (en) * 2008-07-24 2010-01-25 Forem Pharma S R L PREPARED FOR THE CORRECT DEVELOPMENT OF AN INDIVIDUAL.
WO2014204416A1 (en) * 2013-06-21 2014-12-24 Almediko Saglik Urunleri Turizm Gida Sanayi Ve Ticaret Limited Sirketi A solution used in the treatment of hemorrhoid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767062A1 (en) * 1997-08-11 1999-02-12 Andre Pierre Morice COMPOSITION COMPRISING PROPOLIS
FR2773711A1 (en) * 1998-01-16 1999-07-23 Andre Pierre Morice Compositions containing honey and an essential oil or an essential oil derivative with antibacterial and antiviral activity
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767062A1 (en) * 1997-08-11 1999-02-12 Andre Pierre Morice COMPOSITION COMPRISING PROPOLIS
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
FR2773711A1 (en) * 1998-01-16 1999-07-23 Andre Pierre Morice Compositions containing honey and an essential oil or an essential oil derivative with antibacterial and antiviral activity

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915390A1 (en) * 2007-04-24 2008-10-31 Ballot Flurin Apiculteurs Sarl PROCESS FOR TREATING PROPOLIS
WO2008145926A3 (en) * 2007-04-24 2009-02-26 Ballot Flurin Apiculteurs Propolis treatment method
US8257747B2 (en) 2007-04-24 2012-09-04 Ballot-Flurin Apiculteurs Method to treat propolis
US8455007B2 (en) 2007-04-24 2013-06-04 Ballot-Flurin Apiculteurs Method to treat propolis
ITMI20081353A1 (en) * 2008-07-24 2010-01-25 Forem Pharma S R L PREPARED FOR THE CORRECT DEVELOPMENT OF AN INDIVIDUAL.
WO2014204416A1 (en) * 2013-06-21 2014-12-24 Almediko Saglik Urunleri Turizm Gida Sanayi Ve Ticaret Limited Sirketi A solution used in the treatment of hemorrhoid

Also Published As

Publication number Publication date
FR2837105B1 (en) 2004-07-23

Similar Documents

Publication Publication Date Title
Okwu et al. Evaluation of the chemical composition of Dacryodes edulis and Raphia hookeri Mann and Wendl exudates used in herbal medicine in south eastern Nigeria
ES2393285T3 (en) Phytocomplex based on bergamot fruit, manufacturing process and use as a dietary supplement and in the pharmaceutical sector
Ndenecho Herbalism and resources for the development of ethnopharmacology in Mount Cameroon region
Lewis An Experimental History of the Materia Medica, Or of the Natural & Artificial Substances Made Use of in Medicine: Containing a Compendious View of Their Natural History, an Account of Their Pharmaceutic Properties & an Estimate of Their Medicinal Powers.. ̇
TWI655949B (en) Manufacturing method of oral composition and oral composition
FR2837105A1 (en) Synergistic medicinal combination of propolis and lavender essential oil, e.g. as extract obtained by maceration, useful e.g. for treating infections, inflammation, wounds, pain or hemorrhoids
KR20060083915A (en) Oral hygiene composition comprising extract of zanthoxylum schinifolium and manufacturing method thereof
WO2019038100A1 (en) Combination product for relieving the symptoms associated with upper respiratory tract infections
KR101325995B1 (en) Sacbrood of prevention and healing enzyme extract manufacturing method
JP2011522791A (en) Use of plum extract to produce a composition
RU2296579C1 (en) Agent with hepatoprotective and cholagostic action
Jadhav et al. Formulation and evaluation of ointment and liniment using Moringa oleifera seed extract
FR2894483A1 (en) OIL BASED COSMETIC COMPOSITION AND USES THEREOF IN RELIEVING PAIN.
JPWO2018173971A1 (en) Method for producing nasal drop composition, and nasal drop composition
Sivakumar et al. Hepatoprotective effect of Solanum xanthocarpum in paracetamol induced hepatic damage in experimental animals
KR100523746B1 (en) the water solvable propolis manufacturing method by extract of β-cyclodextrin
CN108815235A (en) A kind of antipruritic antiphlogistine in exterior-applied plant source and preparation method thereof
CN107802680A (en) A kind of Chinese medicine external composition for treating paronychia and preparation method thereof
FR2931664A1 (en) PLANT COMPOSITIONS AND USES
JP4527739B2 (en) Treatment or prevention of vascular fibrosis
KR101934811B1 (en) Preparation for improving blood circulation comprising mixed medicinal extracts
Vasey Natural Remedies for Inflammation
RU2139035C1 (en) Dentifrice water
Sifour et al. Burn healing activity of aqueous extract of Atractylis gummifera (L)
RU2617434C2 (en) Vegetable combined cryo-powder based preparations

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20141128